Created in 2013 through the acquisition of the HEMASORB portfolio, Stamford-based ABYRX develops and manufactures synthetic biomaterials and therapeutic devices for surgical procedures. Its best-known products are resorbable hemostatic bone putties, including MONTAGE, a cohesive material that sets after application and resorbs during bone remodeling. The privately held company’s products are protected by more than 50 issued and pending patents.
MedcuraMedcura develops biopolymer-based hemostatic technologies and surgical bleeding-control products, centered on a proprietary hydrophobically modified chitosan platform. Its flagship LifeGel flowable gel received FDA Breakthrough Device Designation in 2022 for procedures where swelling cannot be tolerated, while the company’s scientists and engineers continue developing the platform in formats such as films, powders and gauze. Based in Riverdale, Maryland, Medcura works with surgeons and healthcare professionals throughout product development.RIVERDALE, MD
BC3 TechnologiesFounded in Baltimore in 2018, minority-owned BC3 Technologies develops and manufactures emergency bleeding-control products, including its FDA-cleared SEAL Hemostatic Wound Spray. The company makes and distributes its products in Maryland, drawing on a leadership team with 35 years of medical-device and drug-manufacturing experience and deep backgrounds in chemistry and emergency care.BALTIMORE, MD
Aleo BME, IncFounded by scientists from Pennsylvania State University, State College-based Aleo BME develops and manufactures polymeric biomaterials for medical applications. Its nature-inspired polymer platform has produced ElaSkin® Liquid Bandage, an FDA-cleared product made at the company’s cGMP-compliant Pennsylvania facility, while its research pipeline extends into surgical adhesives and tissue repair.541714STATE COLLEGE, PA
Omni-stat Medical IncEstablished in 2018, Omni-stat Medical develops temporary topical hemostats for controlling bleeding in hospital and emergency-care settings. Its OMNI-STAT and CELOX products use proprietary chitosan granule technology, developed for wounds ranging from minor bleeding to severe arterial injuries and shown to work in the presence of common anticoagulants. The New York-based company is a subsidiary of Medtrade Products Limited and provides product training alongside its clinical solutions.New York, NY